European CDMO formed from Novasep/PharmaZell merger. Specializes in peptide API manufacturing, GLP-1 therapies, and ADCs. €50M investment in peptide purification at Mourenx, France. 9 API manufacturing sites across Europe and India. 2,400+ employees serving 900+ customers.
Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.
Free to claim. Verified upgrades available.